Clinical Trials Directory

Trials / Unknown

UnknownNCT05653726

Multidimensional Impact of Telemonitoring in Heart Failure (IMPACT-HF)

Impact of Noninvasive Telemonitoring on Clinical Events, Healthcare Resource Use and Costs in Heart Failure

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
390 (estimated)
Sponsor
Hospital Universitario 12 de Octubre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to know if telemonitoring and telematic follow-up reduces the healthcare resources utilization, healthcare costs and non-healthcare costs of patients with high-risk heart failure. The main questions it aims to answer are: * Does telematic follow-up reduce de use of healthcare resource utilization of patients with heart failure? * Is telematic follow-up cost-efficient in terms of reducing direct healthcare costs in heart failure patients? * Is telematic follow-up cost-efficient in terms of reducing non-healthcare costs in heart failure patients? Participants will be randomized to usual care (control group) or telematic care (interventional group). Patients randomized to the interventional group will be included in a protocol of daily automatic telemonitoring of arterial pressure, peripheral oximetry, heart rate and weight, and telematic consultations lead by a heart failure clinical specialized team. Researchers will compare the healthcare resource utilization, healthcare and non-healthcare costs of patients randomized to control vs. interventional group.

Conditions

Interventions

TypeNameDescription
OTHERTelemonitoring follow-up using medical devices and telematic consultationsHome telemonitoring of blood pressure, heart rate and peripheral oxygen saturation on a daily basis during 12 months

Timeline

Start date
2023-11-29
Primary completion
2025-06-15
Completion
2025-12-31
First posted
2022-12-16
Last updated
2024-11-27

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05653726. Inclusion in this directory is not an endorsement.